Direct comparison of three methods for predicting digoxin concentrations
- PMID: 8947982
Direct comparison of three methods for predicting digoxin concentrations
Abstract
Three methods of determining digoxin population pharmacokinetic parameters were compared for their abilities to predict 118 measured serum digoxin concentrations (SDCs) in 49 patients. NONMEM software (version IV) was used to generate a residual and a weighted residual for each measured-concentration-predicted-concentration pair. Prediction error analysis was done by a maximum likelihood technique that accounted for several within-patient measures. Data analysis also included graphic observation of weighted residuals (WRES) and calculation of the mean WRES and median absolute prediction error. A further parallel analysis was also carried out on subpopulations with and without concurrent quinidine and congestive heart failure (CHF). Method III was without bias in all subpopulations studied and had the smallest WRES in all populations. Method I was without bias in the overall population, however, it underpredicted SDCs in patients receiving quinidine and in those with CHF. Method II underpredicted SDCs in the overall population, those receiving quinidine, and in patients without CHF. There were no between-method differences in precision as assessed by absolute prediction error.
Similar articles
-
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.Saudi Med J. 2002 Jun;23(6):725-31. Saudi Med J. 2002. PMID: 12070557 Clinical Trial.
-
Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.Clin Pharm. 1984 Mar-Apr;3(2):178-83. Clin Pharm. 1984. PMID: 6723224
-
Enhanced cardiac effect of digoxin during quinidine treatment.Arch Intern Med. 1979 May;139(5):519-21. Arch Intern Med. 1979. PMID: 443945
-
The serum digoxin concentration: ten questions to ask.Am Fam Physician. 1997 Aug;56(2):495-503, 509-10. Am Fam Physician. 1997. PMID: 9262530 Review.
-
[Digoxin in chronic heart failure and sinus rhythm: is the end of the controversy in sight?].Ned Tijdschr Geneeskd. 1997 Mar 8;141(10):460-4. Ned Tijdschr Geneeskd. 1997. PMID: 9173285 Review. Dutch.
Cited by
-
The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.Clin Pharmacokinet. 2000 Dec;39(6):385-95. doi: 10.2165/00003088-200039060-00001. Clin Pharmacokinet. 2000. PMID: 11192472 Review.
-
Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients.Br J Clin Pharmacol. 2003 Aug;56(2):205-13. doi: 10.1046/j.1365-2125.2003.01871.x. Br J Clin Pharmacol. 2003. PMID: 12895194 Free PMC article.
-
Population pharmacokinetics. A regulatory perspective.Clin Pharmacokinet. 1999 Jul;37(1):41-58. doi: 10.2165/00003088-199937010-00003. Clin Pharmacokinet. 1999. PMID: 10451782 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical